These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 3118272)
1. Piridoxilate-associated nephrocalcinosis: a new form of chronic oxalate nephropathy. Vigeral P; Kenouch S; Chauveau D; Mougenot B; Méry JP Nephrol Dial Transplant; 1987; 2(4):275-8. PubMed ID: 3118272 [TBL] [Abstract][Full Text] [Related]
2. Piridoxilate-associated calcium oxalate urinary calculi: a new metabolic drug-induced nephrolithiasis. Daudon M; Reveillaud RJ; Jungers P Lancet; 1985 Jun; 1(8441):1338. PubMed ID: 2860529 [No Abstract] [Full Text] [Related]
3. Piridoxilate-induced calcium oxalate calculi: a new drug-induced metabolic nephrolithiasis. Daudon M; Reveillaud RJ; Normand M; Petit C; Jungers P J Urol; 1987 Aug; 138(2):258-61. PubMed ID: 3599232 [TBL] [Abstract][Full Text] [Related]
4. [Iatrogenic oxalic lithiasis caused by pyridoxilate]. Wolf C; Maistre-Charransol G; Barthelemy C; Ottavioli JN; Thomas E; Thomas J Nephrologie; 1985; 6(5):225-7. PubMed ID: 4094636 [TBL] [Abstract][Full Text] [Related]
5. [Calcium oxalate stones and hyperoxaluria secondary to treatment with pyridoxilate]. Wolf C; Maistre-Charransol G; Barthélémy C; Thomas E; Thomas J; Arvis G; Steg A Ann Urol (Paris); 1985; 19(5):313-7. PubMed ID: 4083839 [TBL] [Abstract][Full Text] [Related]
6. Piridoxilate-induced oxalate nephropathy can lead to end-stage renal failure. Mousson C; Justrabo E; Rifle G; Sgro C; Chalopin JM; Gérard C Nephron; 1993; 63(1):104-6. PubMed ID: 8446234 [TBL] [Abstract][Full Text] [Related]
7. [Resorption of oxalic acid in calcium oxalate nephrolithiasis]. Müller G; Schütte W; Berg W; Möller T Z Urol Nephrol; 1987 Jul; 80(7):391-4. PubMed ID: 3660960 [TBL] [Abstract][Full Text] [Related]
8. Dosimetry considerations in the enhanced sensitivity of male Wistar rats to chronic ethylene glycol-induced nephrotoxicity. Corley RA; Wilson DM; Hard GC; Stebbins KE; Bartels MJ; Soelberg JJ; Dryzga MD; Gingell R; McMartin KE; Snellings WM Toxicol Appl Pharmacol; 2008 Apr; 228(2):165-78. PubMed ID: 18191429 [TBL] [Abstract][Full Text] [Related]
9. [Experimental oxalic lithiasis. Crystallographic study]. Mijan Ortiz JL; Zuluaga Gomez A; De La Fuente Serrano A; Ben el Haddad A J Urol (Paris); 1987; 93(6):337-40. PubMed ID: 3429895 [TBL] [Abstract][Full Text] [Related]
10. [Acute renal failure caused by acute oxalosis after massive ingestion of pyridoxilate]. Dequiedt P; Gosselin B; Benoit O; Le Maguer D; Lebleu J; MacNamara E; Pagniez D; Dracon M; Lelièvre G; Tacquet A Nephrologie; 1985; 6(5):228-30. PubMed ID: 4094637 [TBL] [Abstract][Full Text] [Related]
11. [The significance of oxaluria reduction in pyridoxine prevention of Ca-oxalate nephrolithiasis (author's transl)]. Revúsová V; Gratzlová J; Zvara V; Krídl J; Suchánek B Cas Lek Cesk; 1982 Feb; 121(6):163-6. PubMed ID: 7060073 [No Abstract] [Full Text] [Related]
12. [Recurrent calcium oxalate calculi in patients treated with piridoxylate]. Daudon M; Reveilland RJ; Jungers P Presse Med; 1985 Apr; 14(15):846-7. PubMed ID: 3158917 [No Abstract] [Full Text] [Related]